SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-23-103656
Filing Date
2023-04-17
Accepted
2023-04-17 16:15:57
Documents
4
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 PRE 14A d455357dpre14a.htm PRE 14A 381832
2 GRAPHIC g455357g11l28.jpg GRAPHIC 48746
3 GRAPHIC g455357page001.jpg GRAPHIC 168012
4 GRAPHIC g455357page002.jpg GRAPHIC 101287
  Complete submission text file 0001193125-23-103656.txt   812832
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40656 | Film No.: 23824148
SIC: 2836 Biological Products, (No Diagnostic Substances)